ea0021p105 | Clinical practice/governance and case reports | SFEBES2009
Hatata Hisham
, Abd-Elsalam Mona
, Algohary Ghada
, Okda Sayed
Background: The high prevalence of metabolic syndrome (MS) in schizophrenia has been increasingly recognized in the mental health literature in recent years. The MS is a cluster of the most dangerous known cardiac risk factors (diabetes and prediabetes, abdominal obesity, high cholesterol level, and high blood pressure BP; according to the International Diabetes Federation Criteria, 2007). The existence of an increased mortality risk among people with...